BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1186243)

  • 1. Structure-activity relationships of a series of substituted 17alpha-hydroxy-9beta, 10alpha-progesterones.
    Hartog J; Halkes SJ; Morsink L; De Wachter AM; Schlatmann JL
    J Steroid Biochem; 1975 May; 6(5):577-83. PubMed ID: 1186243
    [No Abstract]   [Full Text] [Related]  

  • 2. Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity.
    Muhn P; Fuhrmann U; Fritzemeier KH; Krattenmacher R; Schillinger E
    Ann N Y Acad Sci; 1995 Jun; 761():311-35. PubMed ID: 7625729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological activity of a new progestogen, 16-methylene-17alpha-hydroxy-18-methyl-19-norpregn-4-ene-3, 20-dione acetate.
    Tuba Z; Bardin CW; Dancsi A; Francsics-Czinege E; Molnár C; Csörgei J; Falkay G; Koide SS; Kumar N; Sundaram K; Dukát-Abrók V; Balogh G
    Steroids; 2000 May; 65(5):266-74. PubMed ID: 10751638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between structure and mode of action of 16 alpha, 17 alpha-cycloalkanoprogesterones (pregna-D'-pentaranes).
    Levina IS; Kamernitzky AV; Fanchenko ND; Simonov VI
    Endokrinologie; 1982 Nov; 80(3):266-74. PubMed ID: 7166158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategy in drug research. Synthesis and study of the progestational and ovulation inhibitory activity of a series of 11beta-substituted-17alpha-ethynyl-4-estren-17beta-ols.
    Broek AJ; Broess AI; Heuvel MJ; de Jongh HP; Leemhuis J; Schönemann KH; Smits J; de Visser J; van Vliet NP; Zeelen FJ
    Steroids; 1977 Oct; 30(4):481-510. PubMed ID: 605457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative study of the progestagenic action of 16 alpha, 17 alpha-cyclohexanoprogesterones (pregna-D'6-pentarans) when administered by different routes].
    Nikitina GV; Korkhov VV; Kulikova LE; Levina IS; Kamernitskiĭ AV
    Farmakol Toksikol; 1988; 51(4):73-5. PubMed ID: 3191979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocrinological studies with desogestrel.
    van der Vies J; de Visser J
    Arzneimittelforschung; 1983; 33(2):231-6. PubMed ID: 6221730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacological study of a non-steroid compound with progestin-like activity (M.G. 6236)].
    Gentili P
    Farmaco Sci; 1976 Aug; 31(8):572-86. PubMed ID: 986318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relation of the progestagenic activity and conformation of the 17beta-acetyl side chain in the D'6-pentarane series].
    Kamernitskiĭ AV; Levina IS; Kulikova LE; Korkhov VV; Nikitina GV
    Bioorg Khim; 1988 Jun; 14(6):828-33. PubMed ID: 3190773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurements of androgenicity. The spectrum of progestogen activity.
    Batzer FR
    J Reprod Med; 1986 Sep; 31(9 Suppl):848-64. PubMed ID: 2945927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological effect of halogen substituted phenyl acetic acid derivatives of progesterone as potent progesterone receptor antagonists.
    Cabeza M; Bratoeff E; Gómez G; Heuze I; Rojas A; Ochoa M; Palomino MA; Revilla C
    J Steroid Biochem Mol Biol; 2008 Sep; 111(3-5):232-9. PubMed ID: 18625316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacology of the new steroid contraceptives].
    Korkhov VV
    Akush Ginekol (Mosk); 1979 Feb; (2):5-8. PubMed ID: 371434
    [No Abstract]   [Full Text] [Related]  

  • 13. Determination of progestational potency: a review.
    Swyer GI
    J R Soc Med; 1984 May; 77(5):406-9. PubMed ID: 6374142
    [No Abstract]   [Full Text] [Related]  

  • 14. Interceptive activities of STS 557 in rabbits, mice and rats.
    Strecke J; Stölzner W; Freund H; Kurischko A; Koch M; Römer W; Stracke R; Oettel M
    Exp Clin Endocrinol; 1983 Feb; 81(2):122-36. PubMed ID: 6406243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biological assay of progestinics and antiprogestinics].
    Chambon Y
    Therapie; 1968; 23(4):703-35. PubMed ID: 4314722
    [No Abstract]   [Full Text] [Related]  

  • 16. Structural requirements for progestational activity. Synthesis and properties of rac-8alpha,9beta,10alpha,14beta-progesterone.
    Solo AJ; Kumar V; Alks V
    J Med Chem; 1979 Feb; 22(2):129-33. PubMed ID: 423192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New-D-homoandrost-4,6-diene derivatives as potent progesterone receptor antagonist.
    Cabeza M; García-Lorenzana M; Garcés M; Heuze I; Teran N; Bratoeff E
    Steroids; 2010 Jan; 75(1):101-8. PubMed ID: 19913568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacology of new gestagens: derivatives of 17-alpha-hydroxyprogesterone].
    Nikitina GV
    Farmakol Toksikol; 1989; 52(3):44-7. PubMed ID: 2792352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sonographic imaging in progestin users and future directions.
    Varma R; Mascarenhas L
    Ultrasound Obstet Gynecol; 2002 Oct; 20(4):322-6. PubMed ID: 12383311
    [No Abstract]   [Full Text] [Related]  

  • 20. [Morphological characteristics of the uterine reaction of androgenized rats in the neonatal period to the administration of sex steroids].
    Arutiunian NA; Proĭmina FI; Savchenko ON; Skopichev VG; Sekretareva EN
    Probl Endokrinol (Mosk); 1987; 33(6):59-61. PubMed ID: 3438270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.